These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35359014)

  • 21. New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort.
    Chen GY; Cao HX; Li F; Cai XB; Ao QH; Gao Y; Fan JG
    J Diabetes Investig; 2016 Mar; 7(2):206-11. PubMed ID: 27042272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.
    Zhu W; Shi P; Fu J; Liang A; Zheng T; Wu X; Yuan S
    Lipids Health Dis; 2022 Dec; 21(1):149. PubMed ID: 36585668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus.
    Mallet V; Parlati L; Martinino A; Scarano Pereira JP; Jimenez CN; Sakka M; Bouam S; Retbi A; Krasteva D; Meritet JF; Schwarzinger M; Thabut D; Rufat P; Bonnefont-Rousselot D; Sogni P; Pol S; Tsochatzis E;
    J Hepatol; 2022 Feb; 76(2):265-274. PubMed ID: 34606913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.
    Jung HS; Chang Y; Kwon MJ; Sung E; Yun KE; Cho YK; Shin H; Ryu S
    Am J Gastroenterol; 2019 Mar; 114(3):453-463. PubMed ID: 30353055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiological investigation of fatty liver disease in Northwest China].
    Yan H; Lu X; Gao Y; Luo J
    Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):622-7. PubMed ID: 26447628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease.
    Kim NH; Jung YS; Hong HP; Park JH; Kim HJ; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2018 Aug; 38(8):1487-1494. PubMed ID: 29359396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.
    Zou Y; Zhong L; Hu C; Sheng G
    Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to a vegetable dietary pattern attenuates the risk of non-alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort study.
    Xia Y; Cao L; Zhang Q; Liu L; Zhang S; Meng G; Wu H; Gu Y; Sun S; Wang X; Zhou M; Jia Q; Song K; Wu Q; Niu K; Zhao Y
    J Intern Med; 2022 Apr; 291(4):469-480. PubMed ID: 34875127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
    Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
    Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
    Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.
    Mansour A; Mohajeri-Tehrani MR; Samadi M; Gerami H; Qorbani M; Bellissimo N; Poustchi H; Hekmatdoost A
    Acta Diabetol; 2019 Nov; 56(11):1199-1207. PubMed ID: 31197470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
    Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
    Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus.
    Huang J; Li R; Liu N; Yi N; Zheng H; Zhang Q; Zhou L; Zhou L; Hu R; Lu B
    J Diabetes Investig; 2021 Nov; 12(11):2019-2027. PubMed ID: 33943028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.
    Reilly NR; Lebwohl B; Hultcrantz R; Green PH; Ludvigsson JF
    J Hepatol; 2015 Jun; 62(6):1405-11. PubMed ID: 25617505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Alcoholic Fatty Liver Disease in Cuba.
    Castellanos-Fernández MI; Crespo-Ramírez E; Del Valle-Díaz S; Barreto-Suárez E; Díaz-Elías JO; Corrales-Alonso S; Morales-Martínez L; Morales-Martínez I; Cedeño-Ramírez E; Pérez-González T; González-Suero SM; Ruenes-Domech C; Infante-Velázquez M; Borges-González SA; Elvírez-Gutiérrez A; Lazo-Del Vallín S; Villa-Jiménez OM; Labrada-Moreno LM
    MEDICC Rev; 2021 Jan; 23(1):64-71. PubMed ID: 33780425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.